Researchers map key human proteins that power coronavirus replication, pointing to new treatment strategies Findings from Scripps Research reveal promising drug targets with potential to block coronaviruses at multiple stages of infection even across different strains.
September 05, 2025
LA JOLLA, CA Despite vaccines and treatments, SARS-CoV-2 the virus that causes COVID-19 continues to pose a global health threat, driven by new variants and its ability to hijack human cells in ways that still aren't fully understood. Now, scientists at Scripps Research have pinpointed dozens of human proteins that SARS-CoV-2 needs to complete its full life cycle, from entering a cell to replicating and releasing new viral particles.
Published in PLOS Biology on June 12, 2025, these findings could open the door to new drug strategies that target our own proteins rather than the virus itself, potentially leading to new treatments effective against SARS-CoV-2 and other coronaviruses, even as the pathogens continue to evolve.
To find out which human proteins SARS-CoV-2 relies on, the research team used a technique called genome-wide small interfering RNA (siRNA) screening. This method can individually inhibit human genes in cells that are naturally susceptible to SARS-CoV-2, revealing which proteins the virus requires to replicate. The team uncovered 32 proteins essential for the earliest stages of infection, 27 proteins that the virus uses later, as well as cellular pathways it exploits some previously known and others newly discovered.
Since the beginning of the pandemic, our lab has long been focused on antivirals that target SARS-CoV-2, but what this work underscores is the importance of shifting toward understanding how the virus interacts with the host, says Sumit Chanda, a professor of immunology and microbiology at Scripps Research and co-senior author of the study. By identifying the human proteins that coronaviruses rely on, we can now think about developing the next generation of pan-coronavirus therapies treatments that could be effective not just against today's SARS-CoV-2, but even a future SARS-CoV-3. Because these strategies target the host, they're also less likely to be undermined by viral mutations and drug resistance.
Among the proteins identified, two emerged as especially promising drug targets. The first, perlecan, is a large protein studded with sugar chains found in the extracellular matrix the supportive meshwork that surrounds and organizes our cells. The research team discovered that SARS-CoV-2's spike protein can latch directly onto perlecan's sugar chains, helping the virus attach to and enter human cells. Blocking that interaction could prevent infection from taking hold.
Perlecan could be acting almost like a co-receptor for the virus, says co-senior author Laura Martin-Sancho, who was formerly a staff research scientist at Scripps Research and is now an assistant professor of molecular virology at Imperial College London. If we can target that interaction, we may be able to stop infection right at the door.
The second protein, Baculoviral IAP Repeat Containing 2 (BIRC2), is part of a cellular inflammation pathway. In cultures of human cells and in mice infected with SARS-CoV-2, drug compounds known as second mitochondria-derived activators of caspases (Smac) mimetics originally developed to trigger cell death in cancer and to wake up dormant HIV so it can be targeted by the therapy successfully inhibited BIRC2, slashing viral levels in an animal model.
With BIRC2, the really striking part is that our lab had been working with Smac mimetics for years in HIV research, adds Chanda. To suddenly see them show antiviral activity against SARS-CoV-2 was a big surprise.
Importantly, the team tested the same human proteins against three other coronaviruses: SARS-CoV-1, MERS-CoV and a seasonal coronavirus. Of the 47 proteins tested, 17 were consistently used by all three viruses, including proteins that help viruses fuse with cells, copy themselves, and exit to infect new cells. This suggests that blocking human proteins that the viruses depend on could form the basis of drugs effective against past, current and potentially future pandemic coronaviruses. Because host-directed antivirals target human proteins rather than viral proteins, they're less likely to be undermined by the virus's rapid mutation rate.
If we have such antivirals ready ahead of time, we could deploy them early in a future coronavirus outbreak, points out Chanda. That gives us a higher barrier to resistance and the potential to block multiple viruses with a single therapy.
Next, the researchers plan to explore whether the same host proteins are also used by other respiratory pathogens such as influenza and RSV. They'll also continue testing the safety and efficacy of promising compounds in future studies.
Authors of the study, Global siRNA screen identifies human host factors critical for SARS-CoV-2 replication and late stages of infection, include Yuan Pu, Laura Riva, Paul D. De Jesus, Daniel Fuentes and Ignacio Mena of Scripps Research; Xin Yin of the Chinese Academy of Agricultural Sciences; Shuofeng Yuan of the Li Ka Shing Faculty of Medicine; Lars Pache of the Sanford Burnham Prebys Medical Discovery Institute; Christopher Churas, Thomas Clausen, Jeffrey D. Esko, Trey Ideker and Dexter Pratt of the University of California San Diego; Stuart Weston, Grace Biddle, Simon Doss-Gollin, Meagan Deming and Matthew B. Frieman of the University of Maryland School of Medicine; Lacy M. Simons, William J. Cisneros and Judd F. Hultquist of Northwestern University Feinberg School of Medicine; Ha Na Kim, John M. Whitelock and Megan S. Lord of the University of New South Wales; and Adolfo Garc a-Sastre of the Icahn School of Medicine at Mount Sinai.
This work was
Most recent headlines
05/01/2027
Worlds first 802.15.4ab-UWB chip verified by Calterah and Rohde & Schwarz to be ...
06/09/2026
June 9 2026, 23:00 (PDT) Dolby and MagentaTV Bring Fans Closer to the FIFA Worl...
04/08/2026
Dalet, a leading technology and service provider for media-rich organizations, t...
04/07/2026
April 7 2026, 19:00 (PDT) Detective Conan: Fallen Angel of the Highway Opens in...
15/06/2026
Detach from Direct-Attached: How Remote Editing with EVO Keeps Creative Teams Mo...
14/06/2026
Library captures 1960s R&B/pop drum sound
Following on from their recent wave of plug-in effects, Iconic Instruments have just launched an all-new virtual d...
14/06/2026
HBO Comedy Rooster Shot with URSA Cine 17K 65
Brie Clayton June 14, 2026
0 Comments
Large format brings viewers intimately close to characters.
Black...
13/06/2026
Latest expansion pack includes 252 presets
Devious Machines have recently introduced another expansion for their powerful multi-effects plug-in, Infiltrator...
13/06/2026
Create custom DAW/plug-in controllers using prompts
MetaGrid have recently introduced an all-new AI Builder function to their touchscreen-based control surf...
13/06/2026
Share
Copy link
Facebook
X
Linkedin
Bluesky
Email...
13/06/2026
Share
Copy link
Facebook
X
Linkedin
Bluesky
Email...
12/06/2026
YES Network and The Gotham Sports App will air seven Athletes Unlimited Softball...
12/06/2026
The United Football League will host its FAST Innovation Suite at the 2026 United Bowl presented by Credit One Bank on Saturday, June 13 at 3:00 p.m. ET at Audi...
12/06/2026
PTZOptics and LayerJot will present live demonstrations at InfoComm 2026 showing how natural-language AI prompting, robotic camera control, and on-device comput...
12/06/2026
MultiDyne Video and Fiber Optic Systems will exhibit at InfoComm 2026, featuring...
12/06/2026
Ateme has announced that Eurovision Services is using Ateme's software-based frame-rate conversion technology for international live event workflows. The de...
12/06/2026
Bitmovin and Simplestream have announced a partnership with Xperi to simplify the launch of OTT streaming services on TiVo OS smart TVs and devices. The collabo...
12/06/2026
Net Insight has announced that a multinational technology company is deploying a...
12/06/2026
MLB Players Inc., the business arm of the MLB Players Association, has announced a partnership with Athletes First to develop and sell brand partnerships across...
12/06/2026
Guntermann and Drunck (G&D) and VuWall have announced the CommandKeyboard-Advanc...
12/06/2026
Comcast Smart Solutions announces a new smart technology deployment with Major L...
12/06/2026
Elevation Worship completed the initial leg of its Elevation Nights 2026 tour ...
12/06/2026
AJA Video Systems has announced KONA IP25 support for Colorfront Transkoder and ...
12/06/2026
Audinate Group Limited (ASX: AD8) will exhibit at InfoComm 2026 (Booth C7321, Ce...
12/06/2026
Pac-12 Commissioner Teresa Gould has announced the appointment of Scott Adametz as Chief Technology Officer. The Pac-12 describes the hire as the first CTO appo...
12/06/2026
Grass Valley has announced AMPP Edge Live, a production system combining Grass Valley hardware, NVIDIA Blackwell GPU acceleration, and AMPP OS in a single platf...
12/06/2026
At one time a trailblazer with the launch of the Longhorn Network, the Universit...
12/06/2026
Ratings Roundup is a rundown of recent rating news and is derived from press rel...
12/06/2026
Chyron has announced PAINT 10.4, an update to its illustrated replay and sports ...
12/06/2026
SVP, Production, Mark Gross: With the new schedule, with not having every Sunday night, it has given us an opportunity to take a step back and reimagine what o...
12/06/2026
For Televisa Technical Engineering Manager Roberto N nez Ibarra and the small team of 12 technicians and two production personnel at the IBC things are already ...
12/06/2026
Simple Steps to Better Acoustics - Taming The Small Room
Most of us mix in spare rooms and small spaces, where the acoustics fight us at every turn. At Gear...
12/06/2026
Latest addition expands vintage-inspired effects palette
Meris' Ottobit pedal range draws its inspiration from vintage gaming consoles, and the latest a...
12/06/2026
Soundbox-based chamber strings series expanded
Sonora Cinematic have just announced the launch of the second instalment in their Soundbox-based chamber stri...
12/06/2026
Share
Copy link
Facebook
X
Linkedin
Bluesky
Email...
12/06/2026
Share
Copy link
Facebook
X
Linkedin
Bluesky
Email...
12/06/2026
AJA Announces KONA IP25 Integration with Colorfront Software
Brie Clayton June 12, 2026
0 Comments
Collaboration enables uncompressed SMPTE ST 2110 I/O ...
12/06/2026
URSA Cine 12K LF Used to Create Visuals for STUTS' K-Arena Concert
Brie Clayton June 12, 2026
0 Comments
Organic visuals projected on a giant scre...
12/06/2026
MTI FILM Acquires Mango New Edit, Expanding its Global Post-Production Services ...
12/06/2026
AI Point Tracking Speeds Up Complex VFX Tracks in Mocha Pro
Jessie Electa Petrov June 12, 2026
0 Comments
The 2026.5 release adds automatic point trac...
12/06/2026
Bitmovin, a provider of video streaming solutions, has partnered with Simplestream, a provider of OTT and broadcast solutions, and technology provider Xperi, to...
12/06/2026
Leostream Corporation, creator of the world-leading Leostream Remote Desktop Access Platform, today announced Jigsaw24, a leading B2B IT solutions provider wit...
12/06/2026
Share
Copy link
Facebook
X
Linkedin
Bluesky
Email...
12/06/2026
Share
Copy link
Facebook
X
Linkedin
Bluesky
Email...
12/06/2026
Share
Copy link
Facebook
X
Linkedin
Bluesky
Email...
12/06/2026
Share
Copy link
Facebook
X
Linkedin
Bluesky
Email...
12/06/2026
Share
Copy link
Facebook
X
Linkedin
Bluesky
Email...
12/06/2026
How Aussie indie games and screen are levelling up with IP 11 June 2026
Ari Harrison, Pro Jank Footy
Head of Games Joey Egger and Ari Harrison of Umbrella sha...
12/06/2026
AgentPerf from Artificial Analysis, the industry's first agentic AI benchmark, gives developers, enterprises and infrastructure providers a clear way to com...
Researchers map key human proteins that power coronavirus replication, pointing to new treatment strategies Findings from Scripps Research reveal promising drug targets with potential to block coronaviruses at multiple stages of infection even across different strains.
